title: Norovirus in immunocompromised patients.
authors.affiliation: Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center in Houston.
authors.forename: Jill
authors.initials: J
authors.lastname: Atmar
authors.forename: Ellen
authors.initials: E
authors.lastname: Mullen
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000930:Antidiarrheals / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D017250:Caliciviridae Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000635:transmission / Q000821:virology*; D003131:Combined Modality Therapy; D004203:Disinfection; D005260:Female; D005440:Fluid Therapy; D005759:Gastroenteritis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000821:virology*; D006235:Hand Disinfection; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D017053:Infection Control / Q000379:methods; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy; D008942:Mitoxantrone / Q000008:administration & dosage; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D029322:Norovirus / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity; D000069283:Rituximab; D017201:Virus Shedding
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000930:Antidiarrheals; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride; D008942:Mitoxantrone